Cargando…

Estrogen receptor beta expression in triple negative breast cancers is not associated with recurrence or survival

BACKGROUND: Triple negative BCa (TNBC) is defined by a lack of expression of estrogen (ERα), progesterone (PgR) receptors and human epidermal growth factor receptor 2 (HER2) as assessed by protein expression and/or gene amplification. It makes up ~ 15% of all BCa and often has a poor prognosis. TNBC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takano, Elena A., Younes, Melissa M., Meehan, Katie, Spalding, Lisa, Yan, Max, Allan, Prue, Fox, Stephen B., Redfern, Andy, Clouston, David, Giles, Graham G., Christie, Elizabeth L., Anderson, Robin L., Zethoven, Magnus, Phillips, Kelly-Anne, Gorringe, Kylie, Britt, Kara L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10197848/ https://www.ncbi.nlm.nih.gov/pubmed/37208678 http://dx.doi.org/10.1186/s12885-023-10795-5

Ejemplares similares

Evaluating statistical approaches to define clonal origin of tumours using bulk DNA sequencing: context is everything
por: Kader, Tanjina, et al.
Publicado: (2022)

Ductal Carcinoma In Situ Biology, Biomarkers, and Diagnosis
por: Gorringe, Kylie L., et al.
Publicado: (2017)

Atypical ductal hyperplasia: update on diagnosis, management, and molecular landscape
por: Kader, Tanjina, et al.
Publicado: (2018)

The genetic architecture of breast papillary lesions as a predictor of progression to carcinoma
por: Kader, Tanjina, et al.
Publicado: (2020)

Exome sequencing of familial high-grade serous ovarian carcinoma reveals heterogeneity for rare candidate susceptibility genes
por: Subramanian, Deepak N., et al.
Publicado: (2020)

Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2015)

Erratum to: Mutational landscape of mucinous ovarian carcinoma and its neoplastic precursors
por: Ryland, Georgina L., et al.
Publicado: (2017)

Targeted therapy for mucinous ovarian carcinoma: evidence from clinical trials
por: Nugawela, Devindee, et al.
Publicado: (2023)

Amplicon-Dependent CCNE1 Expression Is Critical for Clonogenic Survival after Cisplatin Treatment and Is Correlated with 20q11 Gain in Ovarian Cancer
por: Etemadmoghadam, Dariush, et al.
Publicado: (2010)

Molecular comparison of pure ovarian fibroma with serous benign ovarian tumours
por: Hunter, Sally M., et al.
Publicado: (2020)

A rational approach to cancer therapy
por: Gorringe, Kylie L, et al.
Publicado: (2008)

Evaluating the breast cancer predisposition role of rare variants in genes associated with low-penetrance breast cancer risk SNPs
por: Li, Na, et al.
Publicado: (2018)

BRCA2 carriers with male breast cancer show elevated tumour methylation
por: Deb, Siddhartha, et al.
Publicado: (2017)

Estrogen Effects on the Mammary Gland in Early and Late Life and Breast Cancer Risk
por: Dall, Genevieve Victoria, et al.
Publicado: (2017)

When Is “Type I” Ovarian Cancer Not “Type I”? Indications of an Out-Dated Dichotomy
por: Salazar, Carolina, et al.
Publicado: (2018)

The Protein Landscape of Mucinous Ovarian Cancer: Towards a Theranostic
por: Youssef, Arkan, et al.
Publicado: (2021)

Estrogen Actions in Triple-Negative Breast Cancer
por: Treeck, Oliver, et al.
Publicado: (2020)

Functional and genomic characterisation of a xenograft model system for the study of metastasis in triple-negative breast cancer
por: Johnstone, Cameron N., et al.
Publicado: (2018)

Investigation of monogenic causes of familial breast cancer: data from the BEACCON case-control study
por: Li, Na, et al.
Publicado: (2021)

Appraisal of the technologies and review of the genomic landscape of ductal carcinoma in situ of the breast
por: Pang, Jia-Min B., et al.
Publicado: (2015)

Estrogens and Progestogens in Triple Negative Breast Cancer: Do They Harm?
por: van Barele, Mark, et al.
Publicado: (2021)

The Antioxidant and Proapoptotic Effects of Sternbergia clusiana Bulb Ethanolic Extract on Triple-Negative and Estrogen-Dependent Breast Cancer Cells In Vitro
por: El Samarji, Mona, et al.
Publicado: (2023)

Estrogen Receptor Mediates the Radiosensitivity of Triple-Negative Breast Cancer Cells
por: Chen, Xingxing, et al.
Publicado: (2017)

Insights into the Role of Estrogen Receptor β in Triple-Negative Breast Cancer
por: Sellitto, Assunta, et al.
Publicado: (2020)

Mammographic density: a potential monitoring biomarker for adjuvant and preventative breast cancer endocrine therapies
por: Shawky, Michael S., et al.
Publicado: (2016)

Estrogen-induced immune changes within the normal mammary gland
por: Tower, Helen, et al.
Publicado: (2022)

Expression of estrogen receptor beta isoforms in pancreatic adenocarcinoma
por: Younes, Mamoun, et al.
Publicado: (2018)

Gender Differences in Publication Output: Towards an Unbiased Metric of Research Performance
por: Symonds, Matthew R.E., et al.
Publicado: (2006)

Triple-negative breast cancer that progressed as estrogen receptor-positive skin metastases
por: Lee, Sang Min, et al.
Publicado: (2015)

Immunological Differences Between Immune-Rich Estrogen Receptor–Positive and Immune-Rich Triple-Negative Breast Cancers
por: O’Meara, Tess, et al.
Publicado: (2020)

Analysis of the Mitogen-activated protein kinase kinase 4 (MAP2K4) tumor suppressor gene in ovarian cancer
por: Davis, Sally J, et al.
Publicado: (2011)

Functional and Phenotypic Characterisations of Common Syngeneic Tumour Cell Lines as Estrogen Receptor-Positive Breast Cancer Models
por: Lambouras, Maria, et al.
Publicado: (2023)

Lipedema and the Potential Role of Estrogen in Excessive Adipose Tissue Accumulation
por: Katzer, Kaleigh, et al.
Publicado: (2021)

Interactions of dietary estrogens with human estrogen receptors and the effect on estrogen receptor-estrogen response element complex formation.
por: Nikov, G N, et al.
Publicado: (2000)

Copy Number Analysis Identifies Novel Interactions Between Genomic Loci in Ovarian Cancer
por: Gorringe, Kylie L., et al.
Publicado: (2010)

Estrogen receptor-beta is a potential target for triple negative breast cancer treatment
por: Austin, David, et al.
Publicado: (2018)

Molecular profiling of low grade serous ovarian tumours identifies novel candidate driver genes
por: Hunter, Sally M., et al.
Publicado: (2015)

Therapeutic options for mucinous ovarian carcinoma☆
por: Gorringe, Kylie L., et al.
Publicado: (2020)

Mammographically dense human breast tissue stimulates MCF10DCIS.com progression to invasive lesions and metastasis
por: Huo, Cecilia W., et al.
Publicado: (2016)

The CDK4/6 Inhibitor Palbociclib Inhibits Estrogen-Positive and Triple Negative Breast Cancer Bone Metastasis In Vivo
por: Saleh, Lubaid, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ha8p4bliel2rnt918dqpgslv0b